IntelGenx Technologies Corp. Share Price OTC Bulletin Board
Equities
IGX
US45822R1014
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
|
Sales 2022 | 950K 1.3M 79.35M | Sales 2023 | 1.04M 1.42M 86.79M | Capitalization | 24.12M 32.98M 2.02B |
---|---|---|---|---|---|
Net income 2022 | -10M -13.67M -835M | Net income 2023 | -9M -12.31M -752M | EV / Sales 2022 | 44.7 x |
Net Debt 2022 | 7.98M 10.92M 667M | Net Debt 2023 | 13.22M 18.07M 1.1B | EV / Sales 2023 | 35.9 x |
P/E ratio 2022 |
-2.82
x | P/E ratio 2023 |
-2.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.6% |
Latest transcript on IntelGenx Technologies Corp.
Managers | Title | Age | Since |
---|---|---|---|
Dwight Gorham
CEO | Chief Executive Officer | 66 | 13/23/13 |
André Godin
DFI | Director of Finance/CFO | 61 | 20/15/20 |
Horst Zerbe
CHM | Chairman | 77 | 01/06/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Horst Zerbe
CHM | Chairman | 77 | 01/06/01 |
Mark Nawacki
BRD | Director/Board Member | 54 | 09/16/09 |
Bernd Melchers
BRD | Director/Board Member | 72 | 08/09/08 |
1st Jan change | Capi. | |
---|---|---|
+21.22% | 43.81B | |
+30.40% | 23.03B | |
+21.47% | 15.45B | |
+18.96% | 14.4B | |
+58.63% | 12.95B | |
-0.05% | 6.79B | |
-11.84% | 6.49B | |
-8.87% | 5.73B | |
+13.00% | 5.49B |
- Stock Market
- Equities
- IGXT Stock
- IGX Stock